Cost of quality: Health technology assessment

Quality and Safety in Radiotherapy

Volumn , Issue , 2010, Pages 53-57

  Lievens, Yolande ^a   Dunscombe, Peter ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862622721     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b10448     Document Type: Chapter

References (20)

1. Baker, J. J. 1998. Activity-Based Costing and Activity-Based Management for Heallthcare. Gaithersburg, MD: Aspen Publishers.
2. Baumann, M., T. Holscher, and D. Zips. 2008. The future of IGRT-cost benefit analysis. Acta Oncol. 47 (7): 1188-1192.
3. Bodenheimer, T. 2005. High and rising health care costs: Part 2. Technologic innovation. Ann. Intern. Med. 142 (11): 932-937.
4. Delaney, G., S. Jacob, C. Featherstone, and M. Barton. 2005. The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104 (6): 1129-1137.
5. Detsky, A. S., and I. G. Naglie. 1990. A clinician’s guide to costeffectiveness analysis. Ann. Intern. Med. 113 (2): 147-154.
6. Drummond, M. F., M. J. Sculpher, G. W. Torrance, B. O’Brien, and G. L. Stoddart. 2005. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press.
7. Dunscombe, P., and G. Roberts. 2001. Radiotherapy service delivery models for a dispersed patient population. Clin. Oncol. (R. Coll. Radiol.) 13 (1): 29-37.
8. Dunscombe, P., R. Samant, and G. Roberts. 2000. A cost-outcome analysis of adjuvant postmastectomy locoregional radiotherapy in premenopausal node-positive breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 48 (4): 977-982.
9. Laupacis, A., D. Feeny, A. S. Detsky, and P. X. Tugwell. 1992. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 146 (4): 473-481.
10. Lievens, Y., K. Kesteloot, and W. Van den Bogaert. 2005a. CHART in lung cancer: Economic evaluation and incentives for implementation. Radiother. Oncol. 75 (2): 171-178.
11. Lievens, Y., K. Kesteloot, and W. Van den Bogaert. 2005b. Economic consequence of local control with radiotherapy:Cost analysis of internal mammary and medial supraclavicular lymph node radiotherapy in breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 63 (4): 1122-1131.
12. Lievens, Y., W. van den Bogaert, and K. Kesteloot. 2003. Activitybased costing: A practical model for cost calculation in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57 (2): 522-535.
13. Norlund, A. 2003. Costs of radiotherapy. Acta Oncol. 42 (5-6):411-415.
14. OECD. 2009. OECD in Figure 2006-2009. Available from http:// www.oecdobserver.org/news/fullstory.php/aid/1988/OECD_in_Figures_2006-2007.html.
15. Perez, C. A., B. Kobeissi, B. D. Smith, S. Fox, P. W. Grigsby, J. A. Purdy, H. D. Procter, and T. H. Wasserman. 1993. Cost accounting in radiation oncology: A computer-based model for reimbursement. Int. J. Radiat. Oncol. Biol. Phys. 25 (5):895-906.
16. Ploquin, N., and P. Dunscombe. 2009. A cost-outcome analysis of image-guided patient repositioning in the radiation treatment of cancer of the prostate. Radiother. Oncol. 93 (1): 25-31.
17. Ploquin, N. P., and P. B. Dunscombe. 2008. The cost of radiation therapy. Radiother. Oncol. 86 (2): 217-223.
18. Tengs, T. O. 2004. Cost-effectiveness versus cost-utility analysis of interventions for cancer: Does adjusting for health-related quality of life really matter? Value Health 7 (1): 70-78.
19. Van de Werf, E., Y. Lievens, J. Verstraete, K. Pauwels, and W. Van den Bogaert. 2009. Time and motion study of radiotherapy delivery: Economic burden of increased quality assurance and IMRT. Radiother. Oncol. 93 (1): 137-140.
20. Weinstein, M. C. 2008. How much are Americans willing to pay for a quality-adjusted life year? Med. Care. 46 (4): 343-345.